Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Eastern Pharmacy, Inc.
483
•Eastern Pharmacy, Inc.•February 4, 2014

Eastern Pharmacy, Inc. – FDA 483, Feb 4, 2014

Record Details

The FDA Form 483 details significant deficiencies in the repackaging of sterile Avastin (Bevacizumab) and Lucentis (Ranibizumab) drug products into individual syringes from June to December 2013.

The facility lacked established, written, and followed procedures to prevent microbiological contamination. Specifically, there were no written procedures for aseptic process validation, environmental monitoring (which was never performed), gowning, personnel qualification for gowning, or media fills (none conducted). The laminar air flow hood was reportedly used only as a working surface, not turned on. Cleaning procedures for aseptic equipment were inadequate, using only (b)(4) as a cleaning agent.

The aseptic processing area was deficient, lacking a smooth/sealed ceiling, a separating door, temperature/humidity controls, environmental monitoring, and HEPA-filtered positive pressure air supply. The laminar hood was not qualified or certified. Non-sterile gowns were used, and no documentation of sterile gowns or gloves was available.

Personnel lacked adequate training and experience for aseptic processing and gowning, with no documentation provided.

Finished drug products were not laboratory tested for sterility or endotoxin, and no finished product specifications existed for release. There was no written stability testing program, and no stability data supported the 30-day beyond-use-date for the repackaged syringes.

Company
Eastern Pharmacy, Inc.
Inspection date
February 4, 2014
Product type
Drugs
Office
Florida District Office
People
  • Michael H. Tollon (Approval Manager)
  • Carla A. Norris (Retired-FDA Compliance Officer, CDER)
View Company Profile

ID · f01c5e50-28d7-4bcc-b866-43f4ce6158f3

Violation Codes3
21 U.S.C. 324(a)(4)FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Eastern Pharmacy, Inc.
  • WARNING_LETTER - 2014-02-04February 4, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eastern Pharmacy, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.